Have your own idea? Try our Stock Screener
Pakistani (KSE) Pharma Industry Analysis
UpdatedSep 28, 2025
DataAggregated Company Financials
Companies11
- 7D4.1%
- 3M18.5%
- 1Y89.4%
- YTD9.1%
In the last week, the Pharma industry is up 4.1%, with GlaxoSmithKline Pakistan leading the way, up 8.5%. In the last 12 months, the industry was up 89%. Looking forward, earnings are forecast to grow by 22% annually.
Industry Valuation and Performance
Has the Pakistani Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 28 Sep 2025 | PK₨547.1b | PK₨287.3b | PK₨29.1b | 22.5x | 18.8x | 1.9x |
| Tue, 26 Aug 2025 | PK₨531.5b | PK₨281.2b | PK₨26.5b | 24.3x | 20x | 1.9x |
| Thu, 24 Jul 2025 | PK₨481.2b | PK₨279.5b | PK₨26.2b | 22.5x | 18.3x | 1.7x |
| Sat, 21 Jun 2025 | PK₨441.9b | PK₨279.5b | PK₨26.2b | 20.9x | 16.8x | 1.6x |
| Mon, 19 May 2025 | PK₨449.2b | PK₨279.5b | PK₨26.2b | 18x | 17.1x | 1.6x |
| Wed, 16 Apr 2025 | PK₨497.8b | PK₨272.6b | PK₨23.2b | 22.2x | 21.4x | 1.8x |
| Fri, 14 Mar 2025 | PK₨470.3b | PK₨266.0b | PK₨20.9b | 25.6x | 22.5x | 1.8x |
| Sun, 09 Feb 2025 | PK₨489.4b | PK₨257.1b | PK₨19.2b | 23.6x | 25.5x | 1.9x |
| Tue, 07 Jan 2025 | PK₨479.2b | PK₨257.1b | PK₨19.2b | 23x | 25x | 1.9x |
| Thu, 05 Dec 2024 | PK₨458.4b | PK₨257.0b | PK₨19.0b | 22x | 24.1x | 1.8x |
| Sat, 02 Nov 2024 | PK₨343.5b | PK₨254.8b | PK₨18.9b | 17.8x | 18.2x | 1.3x |
| Mon, 30 Sep 2024 | PK₨278.7b | PK₨251.2b | PK₨12.3b | 16.8x | 22.6x | 1.1x |
| Wed, 28 Aug 2024 | PK₨262.5b | PK₨246.7b | PK₨10.8b | 17.9x | 24.4x | 1.1x |
| Fri, 26 Jul 2024 | PK₨240.8b | PK₨243.6b | PK₨8.3b | 16.9x | 29.1x | 1x |
| Sun, 23 Jun 2024 | PK₨243.1b | PK₨243.6b | PK₨8.3b | 16.3x | 29.4x | 1x |
| Tue, 21 May 2024 | PK₨225.6b | PK₨234.6b | PK₨9.0b | 27.2x | 24.9x | 1x |
| Thu, 18 Apr 2024 | PK₨185.5b | PK₨228.8b | PK₨6.6b | 36.1x | 28.2x | 0.8x |
| Sat, 16 Mar 2024 | PK₨167.6b | PK₨224.1b | PK₨6.3b | 20.8x | 26.5x | 0.7x |
| Mon, 12 Feb 2024 | PK₨163.9b | PK₨221.2b | PK₨6.3b | 20.3x | 26.1x | 0.7x |
| Wed, 10 Jan 2024 | PK₨169.7b | PK₨221.2b | PK₨6.3b | 20.3x | 27x | 0.8x |
| Fri, 08 Dec 2023 | PK₨179.9b | PK₨219.1b | PK₨6.1b | 23.3x | 29.3x | 0.8x |
| Sun, 05 Nov 2023 | PK₨149.1b | PK₨218.2b | PK₨6.2b | 20x | 24.1x | 0.7x |
| Tue, 03 Oct 2023 | PK₨122.7b | PK₨209.9b | PK₨7.3b | 11.8x | 16.8x | 0.6x |
| Thu, 31 Aug 2023 | PK₨128.4b | PK₨208.6b | PK₨8.3b | 12.2x | 15.4x | 0.6x |
| Sat, 29 Jul 2023 | PK₨140.4b | PK₨205.6b | PK₨8.7b | 12.8x | 16.1x | 0.7x |
| Mon, 26 Jun 2023 | PK₨124.8b | PK₨205.6b | PK₨8.7b | 11.7x | 14.3x | 0.6x |
| Wed, 24 May 2023 | PK₨137.4b | PK₨199.5b | PK₨11.6b | 12.5x | 11.8x | 0.7x |
| Fri, 21 Apr 2023 | PK₨137.1b | PK₨194.2b | PK₨13.8b | 9.4x | 9.9x | 0.7x |
| Sun, 19 Mar 2023 | PK₨145.5b | PK₨191.5b | PK₨15.1b | 9.7x | 9.7x | 0.8x |
| Tue, 14 Feb 2023 | PK₨150.3b | PK₨189.4b | PK₨15.2b | 10.1x | 9.9x | 0.8x |
| Thu, 12 Jan 2023 | PK₨152.8b | PK₨189.4b | PK₨15.2b | 10x | 10x | 0.8x |
| Sat, 10 Dec 2022 | PK₨169.5b | PK₨188.7b | PK₨15.0b | 11.3x | 11.3x | 0.9x |
| Mon, 07 Nov 2022 | PK₨188.7b | PK₨187.0b | PK₨15.5b | 12.4x | 12.1x | 1x |
| Wed, 05 Oct 2022 | PK₨196.4b | PK₨179.3b | PK₨18.4b | 10.5x | 10.7x | 1.1x |
Price to Earnings Ratio
10.7x
Current Industry PE
- Investors are relatively neutral on the Pakistani Pharmaceuticals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PE ratio of 19.7x.
- The 3-year average PS ratio of 1.1x is lower than the industry's current PS ratio of 1.9x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have grown 16% per year over the last three years.
- Revenues for these companies have grown 17% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Pakistani Healthcare industry?
| PK Market | 2.52% | |
| Healthcare | 3.79% | |
| Pharma | 4.12% | |
| Pharma | 4.12% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| GLAXO GlaxoSmithKline Pakistan | PK₨451.19 | 8.5% +PK₨11.2b | 128.3% | PE15.8x | |
| ABOT Abbott Laboratories (Pakistan) | PK₨1.27k | 9.2% +PK₨10.5b | 64.0% | PE18.8x | |
| AGP AGP | PK₨199.45 | 3.3% +PK₨1.8b | 79.8% | PE16.6x | |
| HINOON Highnoon Laboratories | PK₨1.15k | 0.8% +PK₨493.3m | 66.9% | PE17.3x | |
| CPHL Citi Pharma | PK₨97.57 | 0.7% +PK₨157.6m | 184.1% | PE26.8x |